Treatment | Page 293 of 465

Hypertension :: Differences between blood pressure medicines and newly-diagnosed diabetes

Researchers at Rush University Medical Center analyzed the data from 22 randomized clinical trials, and have found significant differences between antihypertensive drugs. ACE-inhibitors and the newer angiotensin receptor blockers, or ARBs prevent people from getting diabetes, and the older diuretics or beta-blockers, increase the chance that a person becomes diabetic, compared to either placebo (inactive sugar-pills) or calcium channel blockers according to a study published in the January 20, 2007 issue of the Lancet.

Heart Attack :: Aspirin saves lives of cancer patients suffering heart attacks

Many cancer patients who have heart attacks often are not treated with life saving aspirin given the belief in the medical community that they could experience lethal bleeding. Researchers at the University of Texas M. D. Anderson Cancer Center, however, say that notion is now proven wrong and that without aspirin, the majority of these patients will die.

Lung :: Carbon monoxide protects lung cells against oxygen-induced damage

Researchers at the University of Pittsburgh have demonstrated that low-dose carbon monoxide administered in conjunction with oxygen therapy markedly inhibits oxygen-induced damage to lung cells. These findings, being reported in the Jan. 19 issue of the Journal of Biological Chemistry, have significant implications for the treatment of acute respiratory distress syndrome, or ARDS, according to the study’s authors.

Drug Abuse :: Drug treatment seekers more likely to use needle exchange

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examined the connection between Baltimore City?s needle exchange program and drug treatment programs. Individuals who enter treatment programs for drug addiction were more likely to be HIV-positive females who use the Baltimore City needle exchange programs.

COPD :: Increasing awareness, early diagnosis and treatment for COPD

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, in partnership with leading professional societies, health, and advocacy organizations today launches COPD Learn More Breathe Better, a national campaign designed to improve awareness among those at greatest risk for the disease.

Macular Degeneration :: Laser treatment does not prevent vision loss for people with early age-related macular degeneration

An extensive NIH-supported study has found that low-intensity laser treatment, thought to be possibly beneficial in slowing or preventing the loss of vision from age-related macular degeneration (AMD), is ineffective in preventing complications of AMD or loss of vision.

Cancer :: Health Minister Tony Clement supports Tanzania’s efforts to train cancer specialists

The Honourable Tony Clement, Minister of Health, today announced that Canada’s New Government would contribute $150,000 for the training of cancer specialists in Tanzania.

Health :: Warnings about health products – Kang Da and Qing Zhi

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Kidney Cancer :: Pfizer’s Sutent approved for use in Kidney Cancer in Europe

Pfizer Inc said today that Sutent? (sunitinib malate) has received the European Commission?s full marketing authorization for the treatment of advanced and/or metastatic renal cell carcinoma (MRCC), a type of advanced kidney cancer. It is the first multiple receptor tyrosine kinase inhibitor to be approved in the EU for first-line use in MRCC.

Stroke :: Risk of stroke expected to decrease with new screening guidelines

For the first time, a set of screening guidelines for the detection of carotid stenosis, the thickening of the blood vessel that supplies blood to the brain and a leading cause of stroke, has been developed by a multidisciplinary committee of internationally recognized neurologists and surgeons.